The APTIMA HPV assayversusthe hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy

Cervical Cancer Screening

(2017) Edward E. Partridge et al.   Journal of the National Comprehensive Cancer Network

Clinical Performance of a Human Papillomavirus Messenger RNA Test (Aptima HPV Assay) on Residual Material From Archived 3-Year-Old PreservCyt Samples With Low-Grade Squamous Intraepithelial Lesion

(2011) Marianne Waldstrøm et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study

(2011) R S Kelly et al.   BRITISH JOURNAL OF CANCER

Use of HC2 to triage women with borderline and mild dyskaryosis in the UK

(2011) M Arbyn et al.   BRITISH JOURNAL OF CANCER

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous regression of CIN2–3

(2011) Irene T. Ovestad et al.   GYNECOLOGIC ONCOLOGY

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology

(2011) Sveinung Wergeland Sørbye et al.   PLoS One

Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results

(2010) Miriam Reuschenbach et al.   GYNECOLOGIC ONCOLOGY

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

(2010) Joseph Monsonego et al.   INTERNATIONAL JOURNAL OF CANCER

Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

(2010) A. Clad et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cervical Neoplasia Guidelines

(2010) Kate M. Stampler et al.   Journal of Lower Genital Tract Disease

Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears

(2010) Jack Cuzick et al.   JOURNAL OF MEDICAL VIROLOGY

The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer

(2010) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing

(2010) Sveinung Wergeland Sørbye et al.   PLoS One

Statement on HPV DNA Test Utilization

(2009) Diane Solomon et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

(2009) Marc Arbyn et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

(2009) Damon Getman et al.   JOURNAL OF CLINICAL VIROLOGY

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Analytical characterization of the APTIMA® HPV Assay

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

(2008) A. Szarewski et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

(2008) J. Jordan et al.   CYTOPATHOLOGY

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

(2008) P. E. Castle et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE